E-LIB Suche - Ergebnisse für: Razak, Albiruni Ryan Abdul

1

Clinical activity of pembrolizumab in refractory MDM2-ampli..:

Ribeiro, Mauricio Fernando ; Demicco, Elizabeth G. ; Razak, Albiruni Ryan Abdul
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

2

Clinico-demographic characteristics and outcomes of radiati..:

Ribeiro, Mauricio Fernando ; Peretz Soroka, Hagit ; Bhura, Zainab...
Therapeutic Advances in Medical Oncology. 15 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

3

Characterization and outcomes of patients enrolled to multi..:

Kuehne, Nathan ; Chen, Lina ; McDonald, Kate...
Cancer Chemotherapy and Pharmacology. 85 (2019) 2 - p. 469-472 , 2019

Link: https://doi.org/10.1007/..

4

Prognostic and predictive value of CA-125 in the primary tr..:

Díaz-Padilla, Iván ; Razak, Albiruni Ryan Abdul ; Minig, Lucas..
Clinical and Translational Oncology. 14 (2012) 1 - p. 15-20 , 2012

Link: https://doi.org/10.1007/..

5

Carboplatin and pemetrexed in the management of malignant p..:

Li, Louise ; Razak, Albiruni Ryan Abdul ; Hughes, Andrew
Lung Cancer. 64 (2009) 2 - p. 207-210 , 2009

Link: https://doi.org/10.1016/..

6

Retreatment with pemetrexed-based chemotherapy in malignant..:

Razak, Albiruni Ryan Abdul ; Chatten, Katy J. ; Hughes, Andrew N.
Lung Cancer. 60 (2008) 2 - p. 294-297 , 2008

Link: https://doi.org/10.1016/..

7

Medulloblastoma in two successive pregnancies:

Razak, Albiruni Ryan Abdul ; Nasser, Qasiem ; Morris, Patrick..
Journal of Neuro-Oncology. 73 (2005) 1 - p. 89-90 , 2005

Link: https://doi.org/10.1007/..

8

A Pulmonary Lesion Which Is More Than Meets the Eye:

Gunaratnam, Cedric ; Murphy, Desmond ; Razak, Albiruni Ryan Abdul...
Clinical Pulmonary Medicine. 11 (2004) 1 - p. 62-64 , 2004

Link: https://doi.org/10.1097/..

9

Determinants of the recommended phase 2 dose of molecular t..:

Hansen, Aaron R. ; Cook, Natalie ; Amir, Eitan..
Cancer. 123 (2017) 8 - p. 1409-1415 , 2017

Link: https://doi.org/10.1002/..

10

Epithelioid hemangioendothelioma, an ultra-rare cancer : a ..:

Stacchiotti, Silvia ; Miah, Aisha B ; Frezza, Anna Maria...
ESMO open. , 2021

Link: https://ddd.uab.cat/reco..

11

Chemotherapy for malignant germ cell ovarian cancer in adul..:

Razak, Albiruni Ryan Abdul ; Li, Louise ; Bryant, Andrew.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2011

Link: http://www.ncbi.nlm.nih...

12

Muscular Metastasis, A Rare Presentation of Non-Small-Cell ..:

Razak, Albiruni Ryan Abdul ; Chhabra, Rajiv ; Hughes, Andrew...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100076. , 2007

Link: http://www.ncbi.nlm.nih...

13

Clinico-demographic characteristics and outcomes of radiati..:

Mauricio Fernando Ribeiro ; Hagit Peretz Soroka ; Zainab Bhura...
https://doi.org/10.1177/17588359231198943. , 2023

Link: https://doi.org/10.1177/..

14

Phase II randomised discontinuation trial of brivanib in pa..:

Jones, Robin Lewis ; Ratain, Mark M.J ; O'Dwyer, Peter P.J...
uri/info:doi/10.1016/j.ejca.2019.07.024. , 2019

Link: http://hdl.handle.net/20..

15

Determinants of the recommended phase 2 dose of molecular t..:

Hansen, Aaron R ; Cook, Natalie ; Amir, Eitan..
Hansen , A R , Cook , N , Amir , E , Siu , L L & Abdul Razak , A R 2017 , ' Determinants of the recommended phase 2 dose of molecular targeted agents ' , Cancer , vol. 123 , no. 8 , pp. 1409-1415 . https://doi.org/10.1002/cncr.30579. , 2017

Link: https://research.manches..